GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Return-on-Tangible-Equity

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Return-on-Tangible-Equity : -138.06% (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Oxford Cannabinoid Technologies Holdings's annualized net income for the quarter that ended in Oct. 2023 was €-4.61 Mil. Oxford Cannabinoid Technologies Holdings's average shareholder tangible equity for the quarter that ended in Oct. 2023 was €3.34 Mil. Therefore, Oxford Cannabinoid Technologies Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Oct. 2023 was -138.06%.

The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's Return-on-Tangible-Equity or its related term are showing as below:

FRA:0CB' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -372.53   Med: -128.33   Max: -44.36
Current: -106.2

During the past 5 years, Oxford Cannabinoid Technologies Holdings's highest Return-on-Tangible-Equity was -44.36%. The lowest was -372.53%. And the median was -128.33%.

FRA:0CB's Return-on-Tangible-Equity is ranked worse than
75.06% of 1307 companies
in the Biotechnology industry
Industry Median: -48.13 vs FRA:0CB: -106.20

Oxford Cannabinoid Technologies Holdings Return-on-Tangible-Equity Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Return-on-Tangible-Equity Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Return-on-Tangible-Equity
- -371.69 -187.78 -44.40 -64.94

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only -69.87 -31.04 -79.16 -88.62 -138.06

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Return-on-Tangible-Equity

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Return-on-Tangible-Equity falls into.



Oxford Cannabinoid Technologies Holdings Return-on-Tangible-Equity Calculation

Oxford Cannabinoid Technologies Holdings's annualized Return-on-Tangible-Equity for the fiscal year that ended in Apr. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Apr. 2023 )  (A: May. 2021 )(A: Apr. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Apr. 2023 )  (A: May. 2021 )(A: Apr. 2023 )
=-6.752/( (16.358+4.435 )/ 2 )
=-6.752/10.3965
=-64.94 %

Oxford Cannabinoid Technologies Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Oct. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Oct. 2023 )  (Q: Apr. 2023 )(Q: Oct. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Oct. 2023 )  (Q: Apr. 2023 )(Q: Oct. 2023 )
=-4.614/( (4.435+2.249)/ 2 )
=-4.614/3.342
=-138.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Oct. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Oxford Cannabinoid Technologies Holdings  (FRA:0CB) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Oxford Cannabinoid Technologies Holdings Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines